FDA BLA · BLA021716

HYDASE

Sponsor: AKORN INC

APPLICATION

BLA021716

TYPE

BLA

ORIGINAL APPROVAL

2005-10-25

LATEST ACTION

2015-11-05

ROUTE

INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Discontinued

Products

HYDASEDiscontinued

HYALURONIDASE 150 UNITS/ML · INJECTABLE · INJECTION

2015-11-05Labeling · Supplement 3 · standard — Label ↗AP

2005-10-25Type 1 - New Molecular Entity · Original · priority — Other ↗AP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.